CRT 2023
Coronary, Physiology and CMD (Non-CME)
Pieter C. Smits, PhD, FESC
Director Interventional Cardiology
Maasstad Ziekenhuis
Rotterdam, Netherlands
Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Grants/Research Support Recipient (Ongoing); Abiomed: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Arena Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Terminated); AstraZeneca Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Terminated); Daiichi Sankyo, Inc.: Grants/Research Support Recipient (Terminated); MicroPort Medical: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing), Grant Recipient (Ongoing), Scientific Research Study Investigator (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); SMT: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing); Terumo Corporation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)